BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹445 Cr | ₹262 Cr | ₹204 Cr | ₹163 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of BETA DRUGS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹445 Cr |
| Mar2024 | ₹262 Cr |
| Mar2023 | ₹204 Cr |
| Mar2022 | ₹163 Cr |
| Mar2021 | ₹120 Cr |
How is Total Liabilities of BETA DRUGS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹445 Cr | 69.60 | |
| Mar2024 | ₹262 Cr | 28.69 | |
| Mar2023 | ₹204 Cr | 25.06 | |
| Mar2022 | ₹163 Cr | 35.71 | |
| Mar2021 | ₹120 Cr | - | |
Compare Total Liabilities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,301.4 Cr | -1.2% | -6.1% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -1.2% |
-6.1% |
14.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses